EF Hutton Initiates Coverage of UroGen Pharma (LSE:0XOD) with Buy Recommendation
来源:
NASDAQ Stocks
/
15 10月 2024 04:15:24 America/New_York
Fintel reports that on October 14, 2024, EF Hutton initiated coverage of UroGen Pharma (LSE:0XOD) with a Buy recommendation. https://www.nasdaq.com/articles/ef-hutton-initiates-coverage-urogen-pharma-lse-0xod-buy-recommendation
分享